Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07008040

Assessing the Effect of the Silver Dressing on Surgical Site Infections in Adult Patients Post Cardiac Surgery: a Single Center Randomized Control Trial

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
145 (estimated)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RCT on post-cardiac surgery patients using silver dressings vs. standard care. Conducted in ICU, CCU, telemetry units. Outcomes assessed via checklist \& modified Parsonnet Score. Descriptive \& inferential statistics for analysis.

Detailed description

Background The prevalence of surgical site infections in cardiac surgery is about 10%. About 3% of patients who develop an SSI will die as a result. Multiple studies confirm that SSIs are complications with significant sequelae, such as longer hospitalization, increased health costs, increased morbidity, and mortality. Hence, the prevention and management of wound infections in median sternotomy incisions after adult cardiac surgery are crucial for optimizing patient outcomes, 5 Aim To assess the effect of the silver dressing on SSI rates in adult patients post-cardiac surgery. Methodology A single-center randomized control trial approach will be employed. Adult patients admitted post-cardiac surgery with a sternotomy incision will be randomized into the intervention (n=78) or control group (n=77). Units will include the cardiac surgical intensive care unit, the coronary care unit, and the cardiovascular telemetry unit. The intervention will include the use of a silver dressing on the sternotomy incisions and the donor sites where applicable. The control group will follow standard care processes. Data collection will include a checklist and the modified Parsonnet Score. Data analysis will include descriptive and inferential statistics. Conclusion The current rate of surgical site infection amongst cardiac surgical patients is 2.1 below the benchmark of 2.9 with an operational goal of 2.1.

Conditions

Interventions

TypeNameDescription
OTHERSilver dressingSilver dressing will be applied to the sternotomy and donor site wounds for the CABG patients

Timeline

Start date
2025-06-30
Primary completion
2026-06-30
Completion
2026-12-31
First posted
2025-06-06
Last updated
2025-06-06

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT07008040. Inclusion in this directory is not an endorsement.